A detailed history of Cetera Investment Advisers transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 55,927 shares of ADMA stock, worth $991,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,927
Previous 42,153 32.68%
Holding current value
$991,026
Previous $471,000 137.15%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.21 - $20.03 $154,406 - $275,893
13,774 Added 32.68%
55,927 $1.12 Million
Q2 2024

Aug 22, 2024

BUY
$5.98 - $11.18 $252,074 - $471,270
42,153 New
42,153 $471,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.48B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.